NCT06595069View on ClinicalTrials.gov

A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions
Hypercholesterolemia
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT06595069 - A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients | Biotech Hunter | Biotech Hunter